USPTO serial 99835491
LOCK-IN
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, CATHERINE ANNE
- Law office
- TMO LAW OFFICE 110
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with LOCK-IN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Benjamen E. Kern
Benjamen E. Kern Kern Kendrick Pribisich297 Stanbery AveColumbus, OH 43209United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemicals, namely, monoclonal, bispecific, and trimeric or other multispecific antibody formats, and derivatives thereof for in-vivo or in-vitro scientific research and development to treat diseases and for use in laboratories, diagnostics and analytics for scientific or research use | ACTIVE | — |
| 042 | Medical and scientific research in the fields of human or animal monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; medical research services, namely, protein engineering in the fields of human monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; pharmaceutical product development in the fields of human monoclonal or trimeric antibodies to treat diseases; contract research services in the fields of human monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; consulting services in the field of biotechnology and genetic science; consulting services in the field of pharmaceutical research and development; scientific research consulting in the field of biotechnology and bioengineering; providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development of new products for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2026 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Sep 19, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 18, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 17, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 4, 2026 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Sep 4, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| May 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 20, 2026 | NWAP | NEW APPLICATION ENTERED | — |